REMSleep Holdings, Inc. (RMSL) Fair Value 2026

RMSL · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.6 /10

32 fundamental signals · 1 models active

Value Trap Risk

LOW (28/100)

Quick Summary — As of 2026-08-27, REMSleep Holdings, Inc. (RMSL) trades at $0.00. QOC: 4.6/10. Value Trap Risk: 28/100 (LOW). 1/13 models active.

Key Facts

Ticker
RMSL
Price
$0.00
Quality Score
4.6/10
Value Trap Risk
28/100
Models Active
1/13
Last Updated
Strength: 1 independent models provide multi-angle coverage
Risk: Below-average Quality Score of 4.6/10 signals weak fundamentals

What Fair Value Does Each Model Give RMSL?

1 Intrinsic Value Models vs. Current Price ($0.00)

Core Models (Unlocked)
Model Fair Value Upside
Asset-Based · Medium Conviction
 $0.00 -87.7%

All Models Active

All 1 models are displayed above.

What Is REMSleep Holdings, Inc. (RMSL) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, REMSleep Holdings, Inc.'s intrinsic value is estimated at $0.00. Trading at its current price of $0.00, the valuation engine raises significant caution: 1 of 1 models flag downside risk, projecting a median implied return of -87.7%.

What Do the Models Say About RMSL?

1 of 13 models are currently active for RMSL. All 1 active models suggest the stock trades above fair value. See which stocks rank higher →

How Does RMSL Rank in Medical Devices?

Among 157 Medical Devices stocks, RMSL ranks #131 by Quality of Company score. CirclFi's QOC score of 4.6/10 evaluates 32 fundamental signals. A score of 4.6 reflects mixed fundamentals.

See all Most Undervalued Medical Devices Stocks →

REMSleep Holdings, Inc.'s positioning within the Medical Devices segment means that R&D productivity ratio plays an outsized role in fundamental analysis. The sector's unique characteristics — including late-stage pipeline catalysts — shape both the opportunity set and risk profile.

Is RMSL a Value Trap?

CirclFi's Value Trap algorithm assigns RMSL a score of 28/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for REMSleep Holdings, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, REMSleep Holdings, Inc. earns a quality score of 4.6/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every RMSL valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across RMSL's 1 active models, average confidence is 48%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy REMSleep Holdings, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

AEMDAethlon Medical, Inc.QOC 4.7PAVMPAVmed Inc.QOC 4.6ALURAllurion Technologies Inc.QOC 4.8RBOTVicarious Surgical Inc.QOC 4.6TRIBTrinity Biotech plcQOC 4.8CSDXCS Diagnostics Corp.QOC 4.5TCMDTactile Systems Technology, Inc.QOC 8.8CERSCerus CorporationQOC 6.9SSIISS Innovations International, Inc.QOC 6.0IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: AEMD · PAVM · ALUR · RBOT · TRIB · CSDX · TCMD · CERS · SSII · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to RMSL?

7 companies across all industries closest to RMSL’s Quality of Company score of 4.6/10.

VLTInvesco High Income Trust IIQOC 4.6BMEABiomea Fusion, Inc.QOC 4.6ASTLAlgoma Steel Group Inc.QOC 4.6NMRANeumora Therapeutics, Inc.QOC 4.6BDRXBiodexa Pharmaceuticals PlcQOC 4.6RITEMineralRite CorporationQOC 4.6NVDANVIDIA CorporationQOC 10.0

Read investment analysis: VLT · BMEA · ASTL · NMRA · BDRX · RITE · NVDA

Where Does RMSL Sit in CirclFi's Medical Devices Rankings?

RMSL is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About REMSleep Holdings, Inc.’s Valuation?

What is REMSleep Holdings, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for REMSleep Holdings, Inc. (RMSL). The Quality of Company score is 4.6/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is RMSL overvalued or undervalued right now?

At $0.00, 0 of 1 active models suggest RMSL may be undervalued, while 1 indicate potential overvaluation. The assessment depends on which methodology best fits REMSleep Holdings, Inc.'s business model in Medical Devices.

What does a Quality of Company score of 4.6 mean for RMSL?

REMSleep Holdings, Inc.'s QOC of 4.6/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on RMSL?

CirclFi analyzes RMSL with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is RMSL a value trap in 2026?

REMSleep Holdings, Inc.'s Value Trap score is 28/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns REMSleep Holdings, Inc. (RMSL) a Quality of Company score of 4.6/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/RMSL/ · Methodology
Primary sources for this RMSL valuation
  • Financial statements: REMSleep Holdings, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001412126) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for RMSL as of ; valuations recomputed .